Which companies are Shanxi Huaxiang's closest peers?

The cockpit's peer set: CRA International (CRAI), Vcanbio Cell & Gene Engineering (600645.SS), Jadard Technology (688252.SS), Resolute Holdings Management (RHLD), Shanghai MicroPort EP Medtech (688351.SS), Bajaj Mobility (BMAG.SW), China East Education (0667.HK), Shenzhen Aoni Electronic (301189.SZ).

How has Shanxi Huaxiang stock performed?

Over six months to 6 Nov 2026 the shares returned -26.0% against -16.1% for the median peer; over one year -8.1%.

← CockpitCompetitor Analysis › 603112.SS Shanxi Huaxiang Group Co. Ltd. Class AOpen in the cockpit ↗

Shanxi Huaxiang Group Co. Ltd. Class A603112.SSCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Commercial Services

Chinese industrial group; specific business segments not confidently known.

Momentum strong 63

Competitor Analysis ▸ Charts Open in the cockpit

Mkt cap

$1.24B

US dollars, full cap

Free float

37%

of shares outstanding

$/day

$16.5M

20-day average traded

Fwd P/E

12.1×

forward earnings

ROIC−WACC

+4.8 pp

WACC 6.9%

Hurdle

-15 pp

Req g minus delivered

Next earnings

173 days

28 Apr 2027

Close · CNYCN¥15.35

1D+0.4%

1W+2.7%

1M-7.8%

3M+5.7%

6M-26.0%

YTD-11.6%

1Y-8.1%

ATR %5.6%

52w lowhigh35.9% off high

What Shanxi Huaxiang does

Chinese industrial group; specific business segments not confidently known.

Where it sits in the supply chain

Industrials

Moat: none

Headquarters: Shanxi, China · Employees: 6,857

Shanxi Huaxiang at a glance

Size Shanxi Huaxiang (603112.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $1.24B, the 1923rd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥15.35 on 6 Nov 2026.

Performance Over six months the shares fell 26.0%, against -16.1% for the median peer and -16.4% for the China market (cap-weighted) — 6th lowest of 21 in its peer set.

Growth Revenue grew 9.1% over the last twelve months (peer median +12.1%); the operating margin is 11.2% (peer median 9.3%).

Valuation It trades at 12.1× forward earnings against a peer median of 23.1× (4th cheapest of 15).

Price implies For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -15 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 4.8 points above its cost of capital (6.9% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

Six months, rebased to 100: Shanxi Huaxiang against the median of its 20 peers (local-currency closes).

Shanxi Huaxiang financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
	TTM	FY2025	FY2024	FY2023	FY2022
Revenue	CN¥4.39B	CN¥4.12B	CN¥3.82B	CN¥3.25B	CN¥3.22B
Revenue growth	—	+8%	+17%	+1%	—
Gross profit	CN¥1.07B	CN¥849M	CN¥776M	CN¥728M	CN¥546M
EBITDA	n/a	CN¥876M	CN¥736M	CN¥642M	CN¥474M
Net income	CN¥487M	CN¥558M	CN¥471M	CN¥389M	CN¥264M
Free cash flow	CN¥84.4M	-CN¥69.6M	CN¥342M	CN¥202M	-CN¥158M
Capital expenditure	CN¥89.4M	CN¥141M	CN¥140M	CN¥114M	CN¥321M
Total debt	CN¥2.14B	CN¥928M	CN¥1.78B	CN¥1.51B	CN¥1.58B

Quarterly statements and history in the cockpit →

Shanxi Huaxiang competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

Up and to the right = strong over both horizons. Shanxi Huaxiang is the large dot.

Fundamentals: revenue growth against valuation

Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shanxi Huaxiang is the large dot.

Capital: growth delivered against growth the price implies

Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Shanxi Huaxiang is the large dot.

Shanxi Huaxiang competitors and peer comparison

How Shanxi Huaxiang compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shanxi Huaxiang against its 20 peers (data as of 6 Nov 2026)
Measure	603112.SS	Peer median	Rank in peer set
1-month return	-7.8%	+1.3%	8th lowest of 21
6-month return	-26.0%	-16.1%	6th lowest of 21
Distance from 52-week high	-35.9%	-36.9%	10th highest of 21
Revenue growth (TTM)	+9.1%	+12.1%	7th lowest of 21
Operating margin	11.2%	9.3%	9th highest of 21
Forward P/E	12.1×	23.1×	4th cheapest of 15
Growth the price implies (Req g, 7 yrs)	1.4%	11.0%	4th least demanding of 10
Growth delivered (Del g)	+16.2%	+9.0%	4th highest of 9
Hurdle (Req g minus delivered)	-14.8 pp	-12.1 pp	3rd least demanding of 9
ROIC minus cost of capital	+4.8 pp	-0.0 pp	8th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
Company	Market	Market cap	6M return	Revenue growth	Op. margin	Forward P/E	Req g	Delivered g
Shanxi Huaxiang 603112.SS	China	$1.24B	-26%	+9%	11%	12.1×	1.4%	+16.2%
CRA International CRAI	United States	$1.24B	+42%	+11%	10%	22.4×	n/a	n/a
Vcanbio Cell & Gene Engineering 600645.SS	China	$1.23B	-32%	-6%	12%	45.0×	11.0%	+1.9%
Jadard Technology 688252.SS	China	$1.22B	-12%	+6%	12%	23.8×	13.3%	+31.3%
Resolute Holdings Management RHLD	United States	$1.20B	+39%	+10%	9%	n/a	26.0%	n/a
Shanghai MicroPort EP Medtech 688351.SS	China	$1.27B	-23%	+20%	3%	135.2×	41.7%	+26.7%
Bajaj Mobility BMAG.SW	Switzerland	$1.28B	+86%	-47%	-44%	10.4×	n/a	n/a
China East Education 0667.HK	Hong Kong	$1.18B	-18%	+16%	22%	8.4×	-6.1%	+4.1%
Shenzhen Aoni Electronic 301189.SZ	China	$1.18B	-17%	+139%	2%	n/a	n/a	n/a
Beijing Haitian Ruisheng Science Technology 688787.SS	China	$1.17B	-1%	+34%	4%	163.5×	n/a	n/a
SBT Ultrasonic Technology 688392.SS	China	$1.16B	-19%	+42%	17%	52.9×	n/a	n/a
EMTEK (Shenzhen) 300938.SZ	China	$1.16B	-44%	+11%	27%	33.1×	n/a	n/a
Suzhou Novoprotein Scientific 688137.SS	China	$1.33B	+161%	+8%	-62%	n/a	n/a	n/a
Naruida Technology 688522.SS	China	$1.14B	-28%	+20%	14%	22.0×	n/a	n/a
Central Mine Planning & Design Institute CMPDI.NS	India	$1.34B	-15%	+10%	33%	n/a	4.0%	+18.7%
Nittetsu Mining 1515.T	Japan	$1.34B	+10%	+13%	9%	n/a	n/a	n/a
TKC 9746.T	Japan	$1.34B	+21%	+14%	22%	18.1×	-9.9%	+4.2%
Changchun Up Optotech 002338.SZ	China	$1.34B	-39%	+22%	2%	43.4×	n/a	n/a
FESCO 600861.SS	China	$1.11B	-18%	+4%	1%	10.4×	n/a	n/a
SBS 2384.T	Japan	$1.38B	+32%	+22%	6%	14.1×	-8.2%	+13.8%
China Security 600654.SS	China	$1.39B	-31%	-30%	-1%	n/a	56.7%	+0.4%

Questions

Which companies are Shanxi Huaxiang's closest peers?: The cockpit's peer set: CRA International (CRAI), Vcanbio Cell & Gene Engineering (600645.SS), Jadard Technology (688252.SS), Resolute Holdings Management (RHLD), Shanghai MicroPort EP Medtech (688351.SS), Bajaj Mobility (BMAG.SW), China East Education (0667.HK), Shenzhen Aoni Electronic (301189.SZ).
Is Shanxi Huaxiang expensive compared with its peers?: On forward p/e it trades at 12.1× against a peer median of 23.1×, 4th cheapest of 15 in its peer set. For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -15 pp: the price already allows for a slowdown.
How has Shanxi Huaxiang stock performed?: Over six months to 6 Nov 2026 the shares returned -26.0% against -16.1% for the median peer; over one year -8.1%.